raloxifene hydrochloride has been researched along with Body Weight in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.70) | 18.7374 |
1990's | 6 (16.22) | 18.2507 |
2000's | 17 (45.95) | 29.6817 |
2010's | 12 (32.43) | 24.3611 |
2020's | 1 (2.70) | 2.80 |
Authors | Studies |
---|---|
Chan, CO; Mok, DK; Poon, CC; Wong, KY; Wong, MS; Xiao, H; Yu, W; Zhou, L | 1 |
Andrade, TU; Bissoli, NS; Caliman, IF; Dalpiaz, PLM; Firmes, LB; Gouvea, SA; Lamas, AZ; Medeiros, ARS; Nascimento, AM; Oliveira, PWC; Reis, AM; Sousa, GJ | 1 |
Blaeser, A; Bollinger, LE; Harper, AD; Lu, P; Lu, QL; Shah, SN; Sparks, S; Wu, B | 1 |
Kawasaki, N; Nagai, N; Nakazawa, Y; Ogata, F; Otake, H | 1 |
Ilhan, N; Ozercan, IH; Susam, S; Tatar, O | 1 |
Fang, M; Huang, W; Wu, XC | 1 |
Della Torre, S; Eva, C; Fontana, R; Longo, A; Maggi, AC; Meda, C | 1 |
Dullin, C; Hallecker, J; Komrakova, M; Schaefer, N; Sehmisch, S; Stuermer, EK; Stuermer, KM; Tezval, M | 1 |
Chaves-Neto, AH; Dornelles, RC; Ervolino, E; Louzada, MJ; Nakamune, AC; Rossi, AC; Santos, LF; Singulani, MP; Stringhetta-Garcia, CT | 1 |
Ichimura, R; Inoue, K; Kuwata, K; Morikawa, T; Takahashi, M; Usuda, K; Watanabe, G; Yokosuka, M; Yoshida, M | 1 |
Chang, CC; Chang, T; Chuang, CL; Hsin, IF; Hsu, SJ; Huang, HC; Lee, FY; Lee, SD; Lee, WS | 1 |
Fujimura, A; Hasegawa, G; Kaneda, T; Maeda, A; Tsuruoka, S | 1 |
Baird, JP; Fudge, MA; Kavaliers, M; Ossenkopp, KP | 1 |
Hasegawa, Y; Inaji, H; Matsumura, Y; Nakagawa, E; Nishida, M; Ohkita, M; Tanida, I | 1 |
Cegieła, U; Folwarczna, J; Kaczmarczyk-Sedlak, I; Nowińska, B; Pytlik, M; Sliwiński, L; Trzeciak, H; Trzeciak, HI | 1 |
Altunay, H; Bilgili, H; Gecit, MR; Keskin, D; Tasci, A | 1 |
da Silva, BB; dos Santos, AR; Lopes-Costa, PV; Rodrigues-Junior, DM | 1 |
Baron, J; Falk, J; Nilsson, O; Ritzén, EM; Sävendahl, L | 1 |
Fried, A; Segev, E; Wientroub, S; Zeitlin, L | 1 |
Anderson, DW; Bhagwat, SS; Brady, H; Gayo-Fung, LM; Leisten, J; Lipps, SG; McKie, JA; O'Leary, E; Patnaik, N; Stein, B; Sutherland, MK | 1 |
Coppola, A; Di Carlo, C; Di Carlo, R; Esposito, E; Meli, R; Nappi, C; Nasti, A; Pacilio, M; Raso, GM | 1 |
Bracamonte, MP; Jayachandran, M; LaBreche, P; Miller, VM; Mukherjee, R; Okano, H; Owen, WG; Steinkamp, T | 1 |
Leitzbach, D; Linz, W; Madajka, M; Malinski, T; Weckler, N; Wiemer, G | 1 |
Armamento-Villareal, R; Brodt, MD; Caruso, PL; Civelli, M; Civitelli, R; Galbiati, E; Halstead, LR; Mueller, C; Napoli, N; Nawaz, A; Sheikh, S; Silva, MJ | 1 |
Jayachandran, M; Miller, VM; Okano, H; Yoshikawa, A | 1 |
Davis, AM; Ellersieck, MR; Grimm, KM; Rosenfeld, CS | 1 |
Cano, A; del Val, R; García-Pérez, MA; Hermenegildo, C; Noguera, I; Noguera, R | 1 |
Bryant, HU; Evans, G; Magee, D; Sato, M; Turner, RT | 1 |
Bekele, A; Bendele, R; Bensch, WR; Black, LJ; Cullinan, GJ; Kauffman, RF; Magee, DE; Rowley, ER; Sato, M; Williams, DC | 1 |
Black, EC; Bryant, HU; Chandrasekhar, S; Frolik, CA; Magee, DE | 1 |
Bemis, K; Bryant, HU; Burr, DB; Helterbrand, J; Higgs, R; Iversen, P; Owan, I; Sato, M; Smietana, F; Takano, Y; Turner, CH | 1 |
Adrian, MD; Bryant, HU; Rowley, E; Sato, M; Turner, CH; Wang, T | 1 |
Butterworth, M; Greaves, P; Green, A; Parrott, E; White, IN | 1 |
Adámeková, E; Ahlers, I; Ahlersová, E; Bojková, B; Cermáková, M; Chamilová, M; Kalická, K; Kubatka, P | 1 |
Bury, PS; Clarke, CH; Cunningham, KA; de Beun, R; Koldzic-Zivanovic, N; Thomas, ML; Wassermann, K; Zhou, W | 1 |
Bern, HA; Chou, YC; Iguchi, T | 1 |
Jordan, VC; Lindgren, JU; Phelps, E | 1 |
37 other study(ies) available for raloxifene hydrochloride and Body Weight
Article | Year |
---|---|
Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues.
Topics: Alkaline Phosphatase; Animals; Body Weight; Bone and Bones; Breast; Cell Line, Tumor; Central Nervous System; Corpus Striatum; Drugs, Chinese Herbal; Estradiol; Estrogens; Female; Herb-Drug Interactions; Hormones; Humans; Mammary Glands, Human; Medicine, Chinese Traditional; Models, Biological; Ovariectomy; Raloxifene Hydrochloride; Rats, Sprague-Dawley; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus; Water | 2021 |
The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats.
Topics: Active Transport, Cell Nucleus; Animals; Atrial Natriuretic Factor; Body Weight; Estrogens; Female; Heart; Hemodynamics; Myocardium; NF-kappa B; Organ Size; Ovariectomy; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus | 2017 |
Long-Term Treatment of Tamoxifen and Raloxifene Alleviates Dystrophic Phenotype and Enhances Muscle Functions of FKRP Dystroglycanopathy.
Topics: Animals; Body Weight; Bone Density; Dystroglycans; Female; Glycosylation; Heart; Male; Mice, Inbred C57BL; Muscles; Muscular Dystrophy, Animal; Organ Specificity; Pentosyltransferases; Phenotype; Proteins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Transferases | 2018 |
Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment.
Topics: Administration, Cutaneous; Animals; Biological Availability; Body Weight; Calcium; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Liberation; Endocytosis; Male; Menthol; Nanoparticles; Osteoporosis; Ovariectomy; Particle Size; Raloxifene Hydrochloride; Rats, Wistar; Skin Absorption; Solubility | 2018 |
Is there any potential anticancer effect of raloxifene and fluoxetine on DMBA-induced rat breast cancer?
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Carcinogens; Enzyme-Linked Immunosorbent Assay; Female; Fluoxetine; Mammary Neoplasms, Experimental; Raloxifene Hydrochloride; Rats; Rats, Wistar; Weight Gain | 2019 |
Raloxifene upregulated mesangial cell MMP-2 activity via ER-β through transcriptional regulation.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Estrogen Receptor beta; Female; Gene Expression Regulation, Enzymologic; Matrix Metalloproteinase 2; Mesangial Cells; Mice; Protein Kinase Inhibitors; Raloxifene Hydrochloride; Tissue Inhibitor of Metalloproteinase-2; Transcription Factor AP-2; Transcription, Genetic; Up-Regulation | 2013 |
Estrogen replacement therapy regulation of energy metabolism in female mouse hypothalamus.
Topics: Animals; Body Weight; Energy Metabolism; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hypothalamus; Indoles; Mice; Raloxifene Hydrochloride | 2014 |
Whole body vibration during fracture healing intensifies the effects of estradiol and raloxifene in estrogen-deficient rats.
Topics: Animals; Body Weight; Bone Density Conservation Agents; Estradiol; Estrogens; Feeding Behavior; Female; Fracture Healing; Gene Expression; Organ Size; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Vibration; X-Ray Microtomography | 2014 |
The effects of strength training and raloxifene on bone health in aging ovariectomized rats.
Topics: Aging; Animals; Biomarkers; Body Weight; Bone and Bones; Bone Density; Bone Remodeling; Estradiol; Female; Femur; Imaging, Three-Dimensional; Organ Size; Ovariectomy; Raloxifene Hydrochloride; Rats, Wistar; Resistance Training; Uterus | 2016 |
Neonatal exposure to SERMs disrupts neuroendocrine development and postnatal reproductive function through alteration of hypothalamic kisspeptin neurons in female rats.
Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Developmental Disabilities; Disease Models, Animal; Endocrine System Diseases; Estradiol; Estrous Cycle; Female; Hormones; Hypothalamus; Kisspeptins; Neurons; Ovariectomy; Pregnancy; Progesterone; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators; Tamoxifen | 2016 |
Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
Topics: Ammonia; Animals; Body Weight; Female; Fibrosis; Gene Expression Regulation; Hemodynamics; Hepatic Encephalopathy; Hypertension, Portal; Liver; Liver Cirrhosis; Motor Activity; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2017 |
Dosing time-dependent effect of raloxifene on plasma fibrinogen concentration in ovariectomized rats.
Topics: Animals; Body Weight; Calcium; Circadian Rhythm; Female; Fibrinogen; Light; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Time Factors | 2008 |
Tamoxifen and raloxifene produce conditioned taste avoidance in female rats: a microstructural analysis of licking patterns.
Topics: Animals; Behavior, Animal; Body Weight; Conditioning, Operant; Drinking; Female; Humans; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Long-Evans; Selective Estrogen Receptor Modulators; Tamoxifen; Taste | 2009 |
Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Topics: Animals; Blood Pressure; Body Weight; Endothelin-1; Female; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Monocrotaline; Organ Size; Ovariectomy; Pulmonary Artery; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Substrate Specificity; Time Factors; Ventricular Dysfunction, Right | 2009 |
A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Marrow Cells; Bone Resorption; Calcification, Physiologic; Calcium; Cell Count; Cells, Cultured; Disease Models, Animal; Drug Combinations; Estradiol; Estriol; Female; Gene Expression; Genistein; Humans; Mice; Mice, Inbred BALB C; Organ Size; Osteoblasts; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Rats; Rats, Wistar; RNA, Messenger; Selective Estrogen Receptor Modulators; Thymus Gland; Uterus | 2009 |
Biomechanical and histological outcome of combined raloxifene-estrogen therapy on skeletal and reproductive tissues.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Drug Therapy, Combination; Estrogens; Female; Femur; Fractures, Bone; Organ Specificity; Osteopetrosis; Raloxifene Hydrochloride; Rats; Rats, Wistar; Risk; Tibia; Uterus | 2010 |
Effects of tamoxifen and raloxifene on body and uterine weights of rats in persistent estrus.
Topics: Animals; Anovulation; Body Weight; Disease Models, Animal; Female; Organ Size; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus | 2012 |
Raloxifene acts as an estrogen agonist on the rabbit growth plate.
Topics: Animals; Body Weight; Cell Division; Chondrocytes; Contraceptive Agents, Female; Estradiol; Estrogen Antagonists; Female; Growth Plate; Organ Size; Rabbits; Raloxifene Hydrochloride; Tibia; Uterus | 2003 |
Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice.
Topics: Adipose Tissue; Animals; Body Weight; Bone Marrow Cells; Cholesterol; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Female; Fish Oils; Hypolipidemic Agents; Interleukin-1; Interleukin-10; Interleukin-6; Mice; Mice, Inbred BALB C; Ovariectomy; Ovary; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Skin; Spleen; Thiophenes; Triglycerides; Tumor Necrosis Factor-alpha | 2003 |
Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
Topics: Administration, Oral; Animals; Body Weight; Bone Density; Bone Resorption; Cholesterol; Coumarins; Dose-Response Relationship, Drug; Female; Femur; Organ Size; Ovariectomy; Piperidines; Radiography; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Triglycerides; Uterus | 2003 |
Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats.
Topics: Adaptation, Physiological; Adipose Tissue; Animals; Body Weight; Cholesterol; Estradiol; Estrogen Antagonists; Female; Hypothalamus; Leptin; Menopause; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Leptin | 2004 |
Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets.
Topics: Adenosine Triphosphate; Animals; Blood Platelets; Body Weight; Coronary Vessels; Estradiol; Estrogens, Conjugated (USP); Female; Gene Expression; Growth Substances; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Platelet Aggregation; Platelet Count; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Selective Estrogen Receptor Modulators; Sus scrofa | 2005 |
Restoration of endothelial function via enhanced nitric oxide synthesis after long-term treatment of raloxifene in adult hypertensive rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Bradykinin; Endothelium, Vascular; Female; Heart Rate; Hypertension; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Inbred SHR; Selective Estrogen Receptor Modulators; Superoxides | 2005 |
A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Topics: Absorptiometry, Photon; Amino Acids; Animals; Benzopyrans; Biomechanical Phenomena; Blood; Body Composition; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Cholesterol; Compressive Strength; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Femur; Femur Neck; Lumbar Vertebrae; Organ Size; Osteoclasts; Osteogenesis; Ovariectomy; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Tibia; Tomography, X-Ray Computed; Triglycerides; Uterus; Weight-Bearing | 2005 |
Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells.
Topics: Animals; Blotting, Western; Body Weight; Endothelial Cells; Estradiol; Estrogens, Conjugated (USP); Female; Horses; Ligands; Nitric Oxide; Nitric Oxide Synthase Type III; Ovariectomy; Phosphorylation; Raloxifene Hydrochloride; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Swine | 2006 |
The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus.
Topics: Animals; Apoptosis; Body Weight; Cell Line, Tumor; Endometrial Neoplasms; Endometrium; Estrogen Receptor alpha; Estrogen Receptor beta; Female; In Situ Nick-End Labeling; Mice; Mice, Knockout; Organ Size; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sheep; Uterus | 2006 |
Comparative effects of estradiol, raloxifene, and genistein on the uterus of ovariectomized mice.
Topics: Animals; Body Weight; Estradiol; Female; Genistein; Mice; Mice, Inbred C57BL; Ovariectomy; Raloxifene Hydrochloride; Uterus | 2006 |
The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
Topics: Aging; Animals; Body Weight; Bone and Bones; Bone Development; Bone Resorption; Cell Count; Cholesterol; Female; Organ Size; Osteoclasts; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tibia; Uterus | 1994 |
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
Topics: Administration, Oral; Alkaline Phosphatase; Animals; Body Weight; Bone Density; Bone Resorption; Calcium; Cholesterol; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Estrogen Antagonists; Ethinyl Estradiol; Female; Hypertrophy; Ovariectomy; Phosphorus; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Triglycerides; Uterus | 1994 |
Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
Topics: Alendronate; Amino Acids; Animals; Biomarkers; Body Weight; Bone Resorption; Cholesterol; Disease Models, Animal; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Humans; Organ Size; Osteoporosis, Postmenopausal; Ovariectomy; Piperidines; Radioimmunoassay; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1996 |
Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
Topics: Alendronate; Animals; Body Weight; Bone and Bones; Estrogens; Female; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Uterus | 1996 |
LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; Cholesterol; Estrogen Antagonists; Female; Organ Size; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Thiophenes; Uterus | 1998 |
Adenomyosis--a result of disordered stromal differentiation.
Topics: Administration, Oral; Aging; Animals; Animals, Newborn; Body Weight; Calcium-Binding Proteins; Cell Differentiation; Endometriosis; Estradiol; Female; Gene Expression Regulation; Growth Inhibitors; Insulin-Like Growth Factor II; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Myometrium; Nerve Growth Factor; Oligonucleotide Array Sequence Analysis; Organ Size; Raloxifene Hydrochloride; Repressor Proteins; Selective Estrogen Receptor Modulators; Stromal Cells; Tamoxifen; Toremifene; Uterus | 2001 |
Preventive effects of raloxifene and melatonin in N-methyl-N-nitrosourea-induced mammary carcinogenesis in female rats.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Drinking; Eating; Female; Kinetics; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Organ Size; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Uterus | 2001 |
Selective estrogen receptor modulator effects in the rat brain.
Topics: Amygdala; Animals; Body Weight; Brain; Carrier Proteins; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression; Hypothalamus; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Nerve Tissue Proteins; Ovariectomy; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tamoxifen | 2002 |
Effects of antiestrogens on adult and neonatal mouse reproductive organs.
Topics: Animals; Animals, Newborn; Body Weight; Clomiphene; Estrogen Antagonists; Female; Genitalia, Female; Genitalia, Male; Male; Mice; Mice, Inbred C57BL; Nafoxidine; Organ Size; Ovariectomy; Ovary; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Trifluoperazine; Uterus; Vagina | 1992 |
Effects of anti-estrogens on bone in castrated and intact female rats.
Topics: Animals; Body Weight; Bone and Bones; Estradiol; Estrogen Antagonists; Female; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Inbred Strains; Tamoxifen | 1987 |